KRAS, NRAS, and BRAF mutations in plasma cell myeloma at a single Korean institute

BACKGROUND: Plasma cell myeloma (PCM) is a genetically heterogeneous disease. The genetic spectrum of PCM has been expanded to mutations such as KRAS, NRAS, and BRAF genes in the RAS-RAF-MAPK pathway. In this study, we have evaluated the frequency of these mutations and their significance, including...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yonggoo, Park, Sung-Soo, Min, Chang-Ki, Lee, Gun Dong, Son, Jungok, Jo, Sung Jin, Han, Eunhee, Han, Kyungja, Kim, Myungshin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536562/
https://www.ncbi.nlm.nih.gov/pubmed/32989177
http://dx.doi.org/10.5045/br.2020.2020137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536562/
https://www.ncbi.nlm.nih.gov/pubmed/32989177
http://dx.doi.org/10.5045/br.2020.2020137

Ejemplares similares